Efficacy of a Connected Insulin Pen Cap in People With Noncontrolled Type 1 Diabetes: A Multicenter Randomized Clinical Trial
Authors' conclusion
Insulclock system use was associated with improved glycemic control, glycemic variability, hyperglycemia risk, and treatment adherence in people with uncontrolled type 1 diabetes.
Study context
- Population
- People with noncontrolled T1Devaluable
- Participants
- 55 people
- Comparison
- Insulclock connected insulin pen cap in active vs masked mode
- Activen = 26
- Maskedn = 29reference
Methodological detailsmulticentre, open-label, 4-week run-in phase, 6-week double-arm phase
- Multicentre
- Open-label
- 4-week run-in phase
- 6-week double-arm phase
Primary result
As reported in the abstract
Increase in TIR
Active
5.2
%
Masked
−0.8
%
P = 0.016
Further findings
Mean glucose, GMI, TAR and high blood glucose index
- Higher reduction in mean glucose, GMI, TAR and high blood glucose index with Active
On-time insulin doses
- On-time insulin doses increased with Active and decreased with Masked
Original publication
Efficacy of a Connected Insulin Pen Cap in People With Noncontrolled Type 1 Diabetes: A Multicenter Randomized Clinical Trial. Diabetes Care. Published 21 December 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →